MAFLD: what 2 years of the redefinition of fatty liver disease has taught us

Metabolic dysfunction–associated fatty liver disease (MAFLD) has appeared as the leading liver disease worldwide. Whereas the terminology nonalcoholic fatty liver disease (NAFLD) mainly reflected a negative selection and exclusion of alcohol-related liver disease (ALD), the new definition made its f...

Descripción completa

Detalles Bibliográficos
Autores principales: Grabherr, Felix, Grander, Christoph, Effenberger, Maria, Schwärzler, Julian, Tilg, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
New Insights in MAFLD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685107/
https://www.ncbi.nlm.nih.gov/pubmed/36439029
http://dx.doi.org/10.1177/20420188221139101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685107/
https://www.ncbi.nlm.nih.gov/pubmed/36439029
http://dx.doi.org/10.1177/20420188221139101

Ejemplares similares